Guidelines for the management of rheumatoid arthritis: American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

Arthritis and Rheumatism

Volumn 39, Issue 5, 1996, Pages 713-722

  Kwoh, C Kent ^a,b   Simms, Robert W ^a,c   Anderson, Larry G ^a,d   Erlandson, Diane M ^a,e   Greene, Jerry M ^a,f   Moncur, Carolee ^a,g   O'Dell, James R ^a,h   Partridge, Alison J ^a,i   Roberts, W Neal ^a,j   Robbins, Mark L ^a,k   Yood, Robert A ^a,l   Liang, Matthew H ^a,m  

^a Ad Hoc Comm on Clinical Guidelines ^*

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Rheumatology Associates   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f VA BOSTON HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF UTAH   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ Robert B Brigham Multipurpose A   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k HARVARD PILGRIM HEALTH CARE   (United States)

^l Fallon Clinic   (United States)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; GLUCOCORTICOID; GOLD; GOLD SALT; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ARTICLE; BONE MARROW SUPPRESSION; DIARRHEA; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; RASH; RHEUMATOID ARTHRITIS; STOMATITIS; THROMBOCYTOPENIA; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; RHEUMATOLOGY;

EID: 0029985217     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390502     Document Type: Article

References (66)

1. Harris ED Jr: Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277-1289, 1990
2. Hochberg MC: Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. Epidemiol Rev 3:27-44, 1981
3. Allaire SL, Prashker M, Meenan R: The costs of RA. Pharmoeconomics 6:513-522, 1994
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
5. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines: Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 39:723-731, 1996
6. Brook A, Corbett M: Radiographic changes in early RA. Ann Rheum Dis 36:71-73, 1977
7. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T: Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585-591, 1989
8. Möttonen TT: Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 47:648-653, 1988
9. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van't Hof MA, Rijswijk MH, van de Putte LBA: Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 35:26-34, 1992
10. Plant MJ, Saklatvala J, Borg AA, Jones PW, Dawes PT: Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol 21:1808-1813, 1994
11. Van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, van de Putte LB: Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1:1036-1038, 1989
12. Van der Heide A, Jacobs JWG, Bijlsma JWJ, Heurkens AHM, van Booma-Frankfort C, van der Veen MJ, Haanen HCM, Hofman DM: The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 124:699-707, 1996
13. Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for remission in rheumatoid arthritis. Arthritis Rheum 24:1308-1315, 1981
14. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith G, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36:729-740, 1993
15. Goldsmith CH, Boers M, Bombardier C, Tugwell P, for the Omeract Committee: Criteria for clinically important changes in outcomes: development, scoring, and evaluation of the rheumatoid arthritis patient and trial profiles. J Rheumatol 20:561-565, 1993
16. Ahlmen M, Sullivan M, Bjelle A: Team versus non-team out-patient care in rheumatoid arthritis: a comprehensive outcome evaluation including an overall health measure. Arthritis Rheum 31:471-479, 1988
17. Duff IF, Carpenter JO, Neukom JE: Comprehensive management of patients with rheumatoid arthritis: some results of the regional arthritis control program in Michigan. Arthritis Rheum 17:635-645, 1974
18. Clarke AE, Esdaile JM,Hawkins D: Inpatient rheumatic disease units: are they worth it? Arthritis Rheum 36:1337-1340, 1993
19. Helewa A, Goldsmith CH, Lee P, Bombardier C, Hanes B, Smythe HA, Tugwell P: Effects of occupational therapy home service on patients with rheumatoid arthritis. Lancet 337:1453-1456, 1991
20. Helewa A, Bombardier C, Goldsmith CH, Menchions B, Smythe HA: Cost-effectiveness of inpatient and intensive out-patient treatment of rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 32:1505-1514, 1989
21. Katz S, Vignos PJ, Moskowitz RW, Thompson HM, Svec KH: Comprehensive outpatient care in rheumatoid arthritis: a controlled study. JAMA 206:1249-1254, 1968
22. Hicks JE, Nicholas JJ, Swezey RL: Handbook of Rehabilitative Rheumatology. Atlanta, American Rheumatism Association, 1988
23. Raspe HH, Deck R, Mattussek S: The outcome of traditional or comprehensive outpatient care for rheumatoid arthritis (RA): results of an open, non-randomized, 2-year prospective study. Zeitschrift fur Rheumatologie 51 (suppl 1):61-66, 1992
24. Spiegel JS, Spiegel TM, Ward NB, Paulus HE, Leake B, Kane RL: Rehabilitation for rheumatoid arthritis patients: a controlled trial. Arthritis Rheum 29:628-637, 1986
25. Spiegel JS, Spiegel TM, Ward NB: Are rehabilitation programs for rheumatoid arthritis patients effective? Semin Arthritis Rheum 16:260-270, 1987
26. Liang MH, Logigian M: The Rehabilitation of Patients with Early RA. Boston, Little Brown, 1992
27. Swezey RL: Arthritis: Rational Therapy and Rehabilitation. Philadelphia, WB Saunders, 1978
28. Chang RW, editor: Rehabilitation of Persons with Rheumatoid Arthritis. Gaithersburg, MD, Aspen Publishers (in press)
29. Moncur C, Williams HJ: Physical therapy management of patients with rheumatoid arthritis: critical reviews. Phys Rehabil Med 2:11-24, 1990
30. Allaire SH, Partridge AJ. Andrews HF, Liang MH: Management of work disability: resources for vocational rehabilitation. Arthritis Rheum 36:1663-1670, 1993
31. Pincus T, Callahan LF: Remodeling the pyramid or remodeling the paradigms concerning rheumatoid arthritis: lessons from Hodgkin's disease and coronary artery disease. J Rheumatol 17:1582-1585, 1990
32. Greene JM, Winickoff RN: Cost conscious prescribing of non-steroidal antiinflammatory drugs for adults with arthritis: a review and suggestions. Arch Intern Med 152:1995-2002, 1992
33. Silverstein ME, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, Geis GS: Misoprostol reduces serious gastro-intestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 123:241-249, 1995
34. Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS: Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens. Ann Intern Med 123:344-350, 1995
35. Semble EL, Wu WC: Antiinflammatory drugs and gastric mucosal damage. Semin Arthritis Rheum 16:271-286, 1987
36. Easterbrook M: Ocular effects and safety of antimalarial agents. Am J Med 85:23-29, 1988
37. Situnayake RD, Grindulis KA, McConkey B: Longterm treatment of rheumatoid arthritis with sulfasalazine, gold, or penicillamine: a comparison using life table methods. Ann Rheum Dis 46:177-183, 1987
38. Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 17:994-1002, 1990
39. Fehlauer SC, Carson CW, Cannon GW: Two year follow up of treatment of rheumatoid arthritis with methotrexate: clinical experience in 124 patients. J Rheumatol 16:307-312, 1989
40. Weinblatt ME, Kaplan H, Germain BF, Block S, Solomon SD, Merriman RC, Wolfe F, Wall B, Anderson L, Gall E, Torretti D, Weissman B: Methotrexate in rheumatoid arthritis: a five-year prospective multicenter study. Arthritis Rheum 37:1492-1498, 1994
41. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: update after a mean of 90 months. Arthritis Rheum 35:138-145, 1992
42. Alarcón GS, Tracy IC, Blackburn WD Jr: Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32:671-676, 1989
43. Morand EF, McCloud PI, Littlejohn GO: Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 19:704-708, 1992
44. Morgan SL, Baggott JE, Vaughan WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarcón GS: Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. Ann Intern Med 121:833-841, 1994
45. Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcón GS: The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33:9-18, 1990
46. Shiroky JB, Neville C, Esdaile JM, Choquette D, Zummer M, Hazeltine M, Bykerk V, Kanji M, St-Pierre M, Robidoux L, Borque L: Low-dose methotrexate with lucovorin (folonic acid) in the management of rheumatoid arthritis: results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 36:795-803, 1993
47. Kremer JM, Alarcón GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME: Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 37:316-328, 1994
48. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS: Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 99:276-281, 1995
49. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCrum WR: Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Intern Med 80:21-26, 1974
50. Felson DT, Anderson JJ, Meenan RF: The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two metaanalyses. Arthritis Rheum 33:1449-1461, 1990
51. Cash JM, Klippel JH: Second-line drug therapy for rheumatoid arthritis. N Engl J Med 330:1368-1375, 1994
52. Ward JR, Williams HJ, Egger MJ, Reading JC, Boyce E, Altz-Smith M, Samuelson CO Jr, Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M, Kaplan SB, Klippel J: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 26:1303-1315, 1983
53. Dixon ASJ, Davies J, Dormandy TL, Hamilton EB, Holt PJ, Mason RM, Thompson M, Weber JC, Zutshi DW: Synthetic D(-) penicillamine in rheumatoid arthritis: double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis 34:416-421, 1975
54. The Multicentre Trial Group: Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet 1:275-280, 1973
55. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, McKendry R, Tesser J, Baker P, Wells G: Combination therapy with cyclosporin and methotrexate in severe rheumatoid arthritis. N Engl J Med 333:137-141, 1995
56. Wells O, Tugwell P: Cyclosporin A in rheumatoid arthritis: overview of efficacy. BrJ Rheumatol 32 (suppl):51-56, 1993
57. Felson DT, Anderson JJ, Meenan RF: The efficacy and toxicity of combination therapy in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 37:1487-1491, 1994
58. Wilske KR, Healey LA: Remodeling the pyramid - a concept whose time has come. J Rheumatol 16:565-567, 1989
59. Bensen W, Tugwell P, Roberts RM, Ludwin D, Ross H, Grace E, Gent M: Combination therapy of cyclosporin with methotrexate and gold in rheumatoid arthritis (2 pilot studies). J Rheumatol 21:2034-2038, 1994
60. Trnavsky K, Gatterova J, Linduskova M, Peliskova Z: Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol 52:292-296, 1993
61. Haagsm CJ, van Riel PL, de Rooij DJ, Vree TB, Russel FJ, van't Hof MA, van de Putte LB: Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy. Br J Rheumatol 33:1049-1055, 1994
62. Nisar M, Carlisle L, Amos RS: Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis. Br J Rheumatol 33:651-654, 1994
63. Scott DL, Dawes PT, Tunn E, Fowler PD, Shadforth MF, Fisher J, Clarke S, Collins M, Jones P, Popert AJ, Bacon PA: Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebocontrolled study. Br J Rheumatol 28:128-133, 1989
64. Kirwan JR and the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142-146, 1995
65. Meenan RF, Gertman PM, Mason JH: Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 23:146-152, 1980
66. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145, 1980